To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05743270
Title Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | GRC | GBR | FRA | ESP | DEU | CZE